RhoVac AB announced that Peter Buhl Jensen has taken over as the new CEO. Lars Hedbys remains a board member of the Company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 SEK | +51.43% | -.--% | -6.03% |
04-30 | Chosa Oncology AB Announces Resignation of Lars Hedbys as Chairman | CI |
03-28 | Chosa Oncology Names CFO, Chief Commercial Officer | MT |
1st Jan change | Capi. | |
---|---|---|
-6.03% | 3.17M | |
+4.79% | 111B | |
+11.16% | 105B | |
-12.38% | 22.34B | |
-3.84% | 21.93B | |
-6.03% | 18.59B | |
-36.52% | 18.12B | |
-9.89% | 16.96B | |
+2.84% | 13.7B | |
+35.90% | 12.45B |
- Stock Market
- Equities
- CHOSA Stock
- News Chosa Oncology AB
- Rhovac AB Announces CEO Changes